| Email this story to your friends!
GlaxoSmithKline settles overcharging case for $70 million
![](http://www.rawstory.com/images/gsk.jpg") A class action suit has been settled with GlaxoSmithKline for $70 million, the Prescription Access Litigation Project has announced in a statement obtained by RAW STORY.
The case was settled for patients on two GSK drugs, Kytril and Zofran. The drugs are commonly used to ...
(A link to this story will be included in your message)
|
|
